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Effects of sodium artesunate, a new antimalarial drug, on renal by Eiam-Ong and Sitprija [2]. Acute renal failure in
function. malaria falciparum was related to parasitemia [3].
Background. Sodium artesunate is currently used in malaria Artemisin and its derivatives, a new group of anti-treatment. Adverse effects of this drug have not been de-
malarial drugs obtained from a Chinese medicinal herb,scribed, probably because they cannot be differentiated from
qinghao, have been employed in malaria treatment [4].malaria-related effects.
Methods. The effects on renal function of an acute infusion A derivative of artemisin is sodium artesunate, a water-
of sodium artesunate (12 mg/kg body weight) were studied in soluble drug that can be administered by an intravenous
the rat with clearance techniques. We also evaluate the effect or intramuscular injection [5]. This drug is more potentof sodium artesunate on chloride lumen-bath flux (Cl Jlb) in
than quinine and decreases parasite count remarkably.the isolated thick ascending limb of the loop of Henle (TALH)
Up to the present, no important collateral effect hasmicroperfused in vitro.
Results. Acute infusion of artesunate to the rat decreased been shown to occur with these drugs, precisely because
inulin clearance, despite an increase in renal blood flow. These they cannot be differentiated from the proper manifesta-
effects were associated with an increase in urinary excretion
tions of the illness. However, Chinese authors have pre-of sodium, chloride, potassium, and nitric oxide metabolites
viously demonstrated that artesunate inhibits the activity(NO2/NO3). In water-loaded animals, artesunate increased so-
dium and water distal delivery and decreased free water clear- of the Na,K-ATPase of red cells and jejunum [6, 7]. This
ance (CH2O) factored for sodium and water delivery. Following effect might be expected to occur in the renal tubules
hypertonic NaCl infusion, artesunate decreased free water ex- as well.
cretion (TcH2O) corrected by clearance of osmolarity (COsm). In The objective of our study was to evaluate a possiblevitro, artesunate 1026 and 1023 mol/L added to bath solution
effect of sodium artesunate on renal function throughdecreased chloride lumen-bath flux in isolated rabbit TALH
in a dose-dependent manner, with the threshold effect at techniques of clearance and microperfusion in vitro of
1024 mol/L. This effect was completely blocked by NG-nitro- isolated segments of the nephron.
l-arginine-metilester (L-NAME) 5 mmol/L. Artesunate 1024
mol/L added to the perfusion solution did not change Cl Jlb.
Conclusion. These findings suggest that artesunate de- METHODS
creases glomerular filtration rate and increases renal blood
Clearance studiesflow and urinary excretion of Na, Cl, and K. These effects were
due, at least in part, to the inhibition of Cl transport across Male Wistar rats weighing 180 to 240 g were provided
cortical and medullary TALH, and were mediated by local
by the University of Sa˜o Paulo Medical School. The ratsproduction of nitric oxide, since it is associated with an increase
were kept on standard rat chow and tap water until thein NO2/NO3 urinary excretion and it is blocked by L-NAME
in vitro. day of the experiment. The animals were anesthetized
with sodium pentobarbital (50 mg/kg body weight). The
trachea was cannulated with a PE-240 catheter, and the
Malaria is a parasitic disease of great epidemiological animals were maintained under conditions of spontaneous
importance in the tropics [1]. The pathogenesis of acute breathing. The right femoral artery was catheterized with
renal failure in falciparum malaria was reviewed recently a PE-60 catheter to control mean arterial pressure and
to allow blood sampling. The urinary bladder was cannu-
lated with a PE-240 catheter by a suprapubic incision inKey words: malaria falciparum, thick ascending limb of Henle’s loop,
nitric oxide, parasitic disease, tropical disease. order to collect urine samples. Measurements of renal
blood flow (RBF) were done by way of a median incision;Received for publication February 15, 2000
the left renal pedicle was carefully dissected, and theand in revised form September 18, 2000
Accepted for publication September 22, 2000 renal artery was isolated with care to avoid disturbing the
renal nerves. An electromagnetic flow probe (TransonicÓ 2001 by the International Society of Nephrology
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Systems, Bethesda, MD, USA) was placed around the Free water reabsorption
exposed renal artery, and RBF was measured with an Free water excretion (TcH2O) was determined in sixeletromagnetic flowmeter (Transonic Systems, T 106 rats. After anesthesia, surgical preparation and inulin
XM). After completion of the surgical procedure, a load- infusion identical to the anterior protocols, an infusion
ing dose of inulin (100 mg/kg body weight diluted in of hypertonic NaCl solution (2%) was started at a rate of
1 mL of 0.9% saline) was administered through the jugu- 1 mL/h. After an equilibration period of 45 to 60 minutes,
lar vein, followed by a constant infusion of inulin (10 two control periods were collected. Ten minutes after
mg/kg body weight in 0.9% saline) at 0.04 mL/min an intravenous dose of artesunate (12 mg/kg) followed
throughout the experiment, followed at the same time by a continuous infusion of artesunate 0.024 mg/min, at
by another continuous bicarbonate infusion 5% (vehicle a flow rate of 0.0096 mL/min, consecutive periods of 10
of the artesunate) at 0.0096 mL/min during the control to 15 minutes of urine collection were performed. Blood
period. Two urine samples were collected at 30-min- samples were obtained at the beginning and at the end
ute intervals. After an intravenous dose of artesunate of the experiment.
(12 mg/kg), a continuous infusion of artesunate 0.024
mg/min, at a flow rate of 0.0096 mL/min, was started, Microperfusion studies
and three consecutive periods (20 minutes) of urine col- Since the thick ascending limb of the loop of Henle
lection were performed. Blood samples were obtained (TALH) is the nephron segment that presents the
at the beginning and at the end of the last period. greater activity of the Na,K-ATPase for tubule size, we
Inulin clearance values represent the mean for the investigated the artesunate effect on this tubule, with
periods. Blood and urine inulin were determined by the the in vitro microperfusion technique [9].
anthrone method; sodium and potassium concentrations Cortical TALHs were obtained from male New
were measured by flame photometry (model 143; Instru- Zealand rabbits weighing 1.5 to 2.0 kg, which had been
mentation Laboratory, Lexington, MA, USA). Chloride maintained on standard laboratory chow diet with free
concentration was determined in a chloridometer (model
access to water. On the day of the experiments, the
4-2000; Buchler Instruments, Fort Lee, NJ, USA) and
animals were killed by decapitation. The tubules wereurine osmolality in an osmometer (Advanced Instru-
isolated from a small slice immersed in a dish of chilledments, Needham Heights, MA, USA). Glomerular fil-
Ringer/HCO3 buffer, oxygenated and kept at pH 7.4 bytration rate, fractional excretion of sodium, chloride, and
bubbling with 95% O2 1 5% CO2. The TALH segmentspotassium were calculated by standard formulas. Renal
were dissected without the use of collagenase or othervascular resistance was calculated by dividing the value
enzymatic agents. The tubules were transferred to a per-of blood pressure and RBF and was expressed in
fusion chamber that was kept at 378C and pH 7.4 bymm Hg/mL/min.
continuous bubbling with 95% O2 1 5% CO2.
The TALH was perfused with a solution containingFree water clearance
115 mmol/L of NaCl, 25 mmol/L of NaHCO3, 1.2 mmol/LFree water clearance (CH2O) studies were performed of NaH2PO4, 1 mmol/L of CaCl2, 1.2 mmol/L of MgSO4,in seven hydrated rats as previously described [8]. The
and 5.5 mmol/L of glucose, total osmolality 276 mOsm/kgrats received 12 mL of water by gavage at two and one
H2O, and bathed in an identical solution.hours before the beginning of the experiments. The
In the first group of experiments, the measurementswater diuresis was sustained by a water infusion via a
of chloride lumen–bath flux were determined by the rategastric tube at a rate of 0.2 mL/min. After anesthesia
of disappearance of 36Cl added to the perfusate in threeand surgical procedure similar to the anterior study,
periods: (1) control; (2) experimental period, when 1024three urine samples were collected at 10-minute inter-
mol/L sodium artesunate was added to the bath; and (3)vals. Ten minutes after an intravenous dose of artesunate
period of recovery, after the withdrawal of the artesunate(12 mg/kg) followed by a continuous infusion of artesu-
from the bath solution.nate 0.024 mg/min at a flow rate of 0.009 mL/min, consec-
To test whether artesunate acts in a dose-dependentutive 10-minute periods of urine collection were per-
manner, three series of experiments were performedformed. Blood samples were obtained at the beginning
and at the end of the experiment. with the addition of 1023, 1025 and 1026 mol/L sodium
Free water clearance (CH2O) was calculated by the stan- artesunate to the bath.
dard equation, and the fractional delivery of filtrate out In the fifth series of experiments, the 36Cl Jlb was
of the proximal tubule was estimated by the following: measured in three consecutive periods: (1) with control;
(2) after 1024 mol/L of sodium artesunate was added toCNa 1 CH2O/CIn and UV/CIn the luminal fluid; and (3) when artesunate was removed
from the perfusate.where CNa is sodium clearance, CIn is inulin clearance,
and UV is urine volume. In a final series of experiments, the 36Cl Jlb was mea-
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Table 1. Effect of an acute infusion of sodium artesunate onsured in three periods: (1) with control; (2) after the
glomerular filtration rate (GFR), renal blood flow (RBF), arterial
addition of NG-nitro-l-arginine-metilester (L-NAME; pressure (AP), renal vascular resistance (RVR), urine volume (V),
urine osmolality (UOsm), urinary excretion of sodium (UNaV),5 mmol/L) to the basolateral fluid; and (3) when 1024
chloride (UClV) and potassium (UKV), fractional excretion of sodiummol/L of sodium artesunate also was added to the bath
(FENa), chloride (FE Cl), and potassium (FEK)fluid.
Control Artesunate P valueThe lumen-to-bath flux was determined from the rate
GFR mL/min 1.8260.09 0.8860.05 ,0.0001of appearance in the bath of 36Cl added to the perfusate,
RBF mL/min 7.3060.17 8.2060.35 ,0.05maintaining the same chemical chloride concentration in AP mm Hg 11663 10663 ,0.05
the bath and perfusate. For this calculation the following RVR mm Hg/mL/min 16.160.5 13.360.6 ,0.004
UV mL/min 0.00960.002 0.01560.002 ,0.03equation was used:
UOsm mOsm/kg H2 O 1106674 832625 ,0.004
UNaV leQ/min 1.4060.26 2.5060.35 ,0.03Jlb Cl 5
FENa % 0.6260.14 2.4060.33 ,0.0003
Vi/A 60 3 [1 2 Cl c/Cli] 3 [Clp] pEq/cm2/s UClV leQ/min 0.5660.15 1.1060.20 ,0.05
FE Cl % 0.5560.15 2.8260.73 ,0.01where Jlb is the lumen-to-bath flux, and Clp is the chlo- UKV leQ/min 1.4160.28 2.3360.33 ,0.04
FEK % 19.263.9 66.169.6 ,0.0005ride concentration in the perfusion fluid and is equal to
the bath (mEq/L). Vi is the perfusion rate (nL/min), Values are mean 6 SEM; N 5 8 rats
equal to the collected rate (nL/min) measured for the
precalibrated volumetric micropipette. 36Clc 5 concen-
tration of 36Cl in the collected fluid (counts/min). 36Cli is
(0.28 mmol/L; Sigma Chemical Co.), 100 mL of flavinthe concentration of 36Cl in the perfusion fluid (counts/
adenine dinucleotide (35 mmol/L; Sigma Chemical Co.),min). A is the area and was calculated and expressed as
and 200 mL of potassium phosphate buffer (0.1 mol/L31024 cm2.
KH2PO4, pH 7.2). A standard curve was constructed forThis equation is based on the fact that 36Cl is a perfect
each assay and consisted of 2, 4, 10, and 20 nmol/L permarker of Cl.
tube of NaNO3. After two hours of incubation at 258C,Timed fluid collections were made with a constant-
the reaction was terminated by heating for three minutesvolume constriction pipette that was rinsed four times
in a boiling water bath. Triplicate samples were thenwith 0.5 mL of water; 5 mL of scintillation liquid were
incubated with 700 mL of Griess reagent (a 1/1 mixturethen pipetted into the vial (Aquasol universal cocktail;
of 2% sulfanilamide in 5% HPO4 and 0.2% napthylethy-New England Nuclear, Boston, MA, USA). The isotopic
lendiamine dihydrochloride in water) for 10 minutes atconcentration was determined with a liquid scintillation
608C to form a stable azo-dye, which was measured byspectrometer (Tri-Carb 1600TR; Packard, Downers
spectrophotometer at 546 nm (Spectrophotometer U2000;Grove, IL, USA). The isotopic materials used were from
Hitachi, Tokyo, Japan). The conversion of NO3 to NO2Amersham International and New England Nuclear. All
must range from 90 to 100%.other drugs were purchased from Sigma Chemical (St.
Louis, MO, USA).
Statistical analysis
Nitrite (NO2) and nitrate (NO3) measurements Results are reported as mean 6 SEM. Clearance stud-
ies were analyzed statistically by Student t test. DataThe effect of artesunate administration on the urinary
for microperfusion studies were analyzed by analysis ofexcretion of nitrite (NO2) and nitrate (NO3), the stable
variance, followed by the Student-Newman-Keuls post-oxidation products of the NO, was measured in six rats
test. The significance was set at P , 0.05.in two consecutive one-hour periods: (1) with control
and (2) during artesunate administration in intravenous
bolus (12 mg/kg) followed by a continuous infusion of RESULTS
0.024 mg/min during one hour. The surgical preparation
Renal function studiesand urine and plasma collection of these animals were
The results of the clearance studies are shown in Tablethe same as for the other group from the first part of
1. The inulin clearance decreased following acute infu-the experiment. The determination of urinary excretion
sion of sodium artesunate (0.88 6 0.05 vs. 1.82 6 0.09 mL/of NO metabolites (NO2 and NO3) was done by the
min, P , 0.0001). This decrease occurred in the presenceGriess reaction [10]. For the NO2 and NO3 assays, the
urine samples were diluted 10 to 50 times with Milliq of renal vasodilation, since RBF had increased from
7.30 6 0.17 to 8.20 6 0.35 mL/min; P , 0.05) consequent,water. The reduction of NO3 to NO2 was performed using
nitrate reductase (Sigma Chemical Co.). Each diluted at least in part, to a decrease in renal vascular resistance
from 16.1 6 0.5 to 13.3 6 0.6 mm Hg/mL/min; P ,urine sample (220 mL) was incubated with 100 mL of
nitrate reductase (43 mm/mL), 100 mL of b-NADPH 0.004). At this dose, artesunate also produced a small
Campos et al: Artesunate effects on renal function 1047
Table 2. Effect of an acute infusion of sodium artesunate on free
water excretion (N 5 7 rats)
Control Artesunate P value
C In mL/min 2.1360.20 1.2660.80 ,0.002
UOsm mOsm/kg H2 O 8066 156611 ,0.001
UV/C In 9.761.6 23.766.3 ,0.05
FENa % 1.360.5 8.963.4 ,0.05
C H 2O mL/min 0.12960.016 0.10360.021 NS
(C Na 1 C H 2O)/C In % 8.361.0 18.564.5 ,0.05
C H 2O /(C Na 1 C H 2O) % 78.166.9 49.664.8 ,0.005
C H 2O /UV % 67.562.9 40.264.1 ,0.001
Abbreviations are: C In, inulin clearance; UOsm, urine osmolality; UV, urine
volume; FENa, sodium fractional excretion; CH2O, free water clearance; C Na 1
C H2O, distal sodium delivery. Data are mean 6 SEM.
decrease in mean arterial pressure from 116 6 3 mm Hg
to 106 6 3 mm Hg (P , 0.05).
The urine volume increased after artesunate infusion
(0.015 6 0.002 vs. 0.009 6 0.002 mL/min, P , 0.03). The
urine osmolality was lower after the drug administration
(832 6 25 vs. 1106 6 74 mOsm/kg H2O; P , 0.004),
Fig. 1. Effect of sodium artesunate on free water clearance normalizedsuggesting a defect of urine concentration (Table 1). The
by urine volume (CH2O/UV) in seven rats. After a control period of 30fractional excretion of sodium increased after artesunate minutes, artesunate 12 mg/kg body weight was intravenously bolus
injected followed by an intravenous infusion at 0.024 mg/min. The valuesadministration (2.40 6 0.33% vs. 0.62 6 0.14%; P ,
are the means 6 SEM. *P , 0.05 vs. control periods.0.0003), as well as the fractional excretion of chloride
(2.82 6 0.73% vs. 0.55 6 0.15%; P , 0.01), and the
fractional excretion of potassium (66.1 6 9.6% vs. 19.2 6
3.9%; P , 0.0005; Table 1).
Free water clearance determinations were conducted
during maximum aqueous diuresis and the results are
summarized in Table 2. The intravenous injection of
sodium artesunate produced significant decrease in inu-
lin clearance and an increase in urine osmolality from
80 6 6 to 156 6 11 mOsm/kg H2O. Distal sodium delivery
estimated by both UV/CIn or by CNa 1 CH2O/CIn increased
significantly (about twofold) after artesunate administra-
tion, suggesting that artesunate decreased the fractional
water and sodium reabsorption in the proximal tubule.
The CH2O did not change after the drug administration,
however, when CH2O was corrected for distal sodium de-
livery (CH2O/CNa 1 CH2O), it decreased after artesunate
Fig. 2. Relationship between free water reabsorption (TcH2O) and os-injection from 78.1 6 6.9 to 49.6 6 4.8% (P , 0.005).
molar clearance (COsm) in the control period (d) and after artesunateAs shown in Figure 1, CH2O normalized by urine volume infusion (s). The six rats were maintained on a constant infusion of
decreased during treatment with sodium artesunate. 2% NaCl solution.
These results indicate that artesunate produced an im-
pairment of the diluting segments.
The free water excretion (TcH2O) experiments are
during hypertonic saline infusion. All of the values ob-shown in Table 3. The inulin clearance decrease after
tained after the artesunate infusion were below the lowerartesunate administration from 2.17 6 0.07 to 1.24 6
limits for control periods. These results suggest that arte-0.06 mL/min (P , 0.0001). The TcH2O was not significantly
sunate decreases sodium and chloride reabsorption indifferent from control period; however, when it was cor-
the medullary thick ascending limb of Henle.rected by the clearance of osmolarity (COsm), it decreased
from 77.0 6 0.5 to 47.8% (P , 0.0005). These findings As shown in Figure 3, the NO2 1 NO3 urinary excre-
tion increased from 2.0 6 1.4 to 4.7 6 2.1 nmol/L/hourcan be better visualized in Figure 2, where the TcH2O was
plotted as a function of COsm for all clearance periods (P , 0.01) after sodium artesunate infusion.
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Table 3. Effect of an acute infusion of sodium artesunate on free
water reabsorption (N 5 6 rats)
Control Artesunate P value
C In mL/min 2.1760.07 1.2460.06 ,0.0001
UOsm mOsm/kg H2 0 1272641 597684 ,0.0001
UV mL/min 0.01060.002 0.04260.006 ,0.003
C Osm mL/min 0.04160.008 0.08260.007 ,0.004
TcH 2O mL/min 0.03160.006 0.04060.007 NS
TcH 2O/C Osm % 77.060.5 47.865.8 ,0.0005
Abbreviations are: C In, inulin clearance; UOsm, urine osmolality; UV, urine
volume; C Osm, osmolar clearance; TcH2O, free water reabsorption. Data are
mean 6 SEM.
Fig. 4. Effect of sodium artesunate (1024 mol/L) added to peritubular
fluid on 36Cl lumen-bath (Jlb) in the thick ascending loop of Henle
(TALH). Five consecutive experiments in three periods are shown: (1)
with control, (2) after an addition of sodium artesunate to bath fluid,
and (3) when sodium artesunate was withdrawn from bath fluid. Each
point represents the mean of three collections of one period. Lines
connect data points of individual tubules.
Table 4. Dose-dependent effect of artesunated added to the bath
fluid on lumen-to-bath 36Cl of the rabbit cortical thick ascending
limb of Henle’s loop
36Cl Jlb pEq/cm2/sFig. 3. Effect of an acute infusion of sodium artesunate on urinary
NO2 1 NO3 excretion in six rats, before (control period) and following Concentration mol/L Control Artesunate Recovery
artesunate infusion (artesunate period).
1026 (N55) 1112623 923621a,b 1113628
1025 (N55) 1114613 785629 a,c 1119620
1024 (N55) 1138642 624618a 1024619
1023 (N55) 1093626 683616a 991627
Microperfusion studies
Values are mean 6 SEM. Number of tubules is shown in parentheses.
aP ,0.001 vs. control and recoveryIn the first series of experiments (N 5 5), sodium
bP ,0.001 vs. other groups
artesunate 1024 mol/L added to the bath decreased the cP ,0.01 vs. 1024 and 1023 mol/L
Jlb of chloride from 1138 6 41 to 624 6 18 pEq/cm2/s
(P , 0.001), returning to a value similar to control
(1024 6 19), when artesunate was removed from the
Since previous studies have shown that endogenousbath (Fig. 4).
nitric oxide inhibits chloride transport in TALH and ourTable 4 and Figure 5 show the dose-dependent effect
finding showed that artesunate increases urinary excretionobserved after the addition of 1023 to 1026 mol/L artesu-
of NO metabolites, we evaluated the effect of NO synthasenate to the bath. From 1026 to 1024 mol/L doses of artesu-
inhibition with L-NAME on artesunate’s action in the
nate, a gradual decrease in Jlb of chloride was observed.
TALH. As illustrated in Figure 7, the 36Cl Jlb was 1097 6
The maximum effect was reached at the dose of
38 in the control period, 1098 6 39 after the addition
1024 mol/L, suggesting a threshold effect. of L-NAME to the bath and 1116 6 36 in the presence
These data indicate that artesunate decreased the re- of L-NAME and artesunate 1024 mol/L in the peritubular
absorption of chloride in the TALHs when added to fluid. These experiments indicate that L-NAME blocked
peritubular fluid in a dose-dependent manner. the effect of the artesunate of sodium on the TALHs.
To determine whether the inhibitory effect of sodium
artesunate on chloride absorption occurs when the drug
DISCUSSIONis present at the luminal side, we perfused another five
tubules. As shown in Figure 6, sodium artesunate Sodium artesunate is a new antimalarial drug, charac-
1024 mol/L did not modify the Cl Jlb. These results sug- terized by an immediate and rapid reduction of para-
gest that artesunate does not act in the luminal mem- sitemia with high efficacy in resistant parasites strains
[4, 5]. Recently, we reported a patient with malaria falci-brane.
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Fig. 5. Effect of sodium artesunate (1023 to 1026 mol/L) added to
peritubular fluid on 36Cl lumen-bath (Jlb) in TALH. Three periods are
shown: (1) with control, (2) after addition of sodium artesunate to bath
Fig. 6. Effect of sodium artesunate (1024 mol/L) added to luminal fluidfluid, and (3) when sodium artesunate was withdrawn from bath fluid.
on 36Cl lumen-bath (Jlb) in TALH. Five consecutive experiments inEach point represents the mean 6 SEM. Symbols are: (j) 1023 mol/L;
three periods are shown: (1) with control, (2) after an addition of sodium(m) 1024 mol/L; (.) 1025 mol/L; (r) 1026 mol/L.
artesunate to perfusate, and (3) when sodium artesunate was withdrawn
from luminal fluid. Each point represents the mean of three collections
of one period. Lines connect data points of individual tubules.
parum who presented a serious respiratory insufficiency
without renal failure (abstract; Campos et al, J Am Soc
Nephrol 9:128A, 1998). This patient was treated with
four habitual doses of sodium artesunate (60 mg/kg intra-
venously) at 0, 4, 24 and 48 hours. Diuresis and natriure-
sis began rise immediately after artesunate administra-
tion and declined to normal values at the end of the
treatment.
This diuretic effect was confirmed in the present study
with the development of an experimental model in the
rat treated with sodium artesunate. One hour of sodium
artesunate infusion caused a decrease in blood pressure
and an increase in RBF. As observed with furosemide,
the artesunate-induced renal vasodilation may be related
to the inhibitory effect of this drug on chloride transport
across the cortical TALH, which suppresses tubuloglom-
erular feedback [11, 12]. This effect may also be mediated
by nitric oxide, which is synthesized by the macula densa Fig. 7. L-NAME inhibits the sodium artesunate-induced decrease in
36Cl lumen-to-bath (Jlb) in isolated TALH. An addition of 1024 mol/Land acts to disrupt tubuloglomerular feedback [13]. The
sodium artesunate to the bath fluid of TALH pretreated with 5 mmol/L
observed 50% reduction in glomerular filtration rate may L-NAME did not change 36Cl Jlb.
be due to a decrease in glomerular ultrafiltration coeffi-
cient (Kf) or to a greater decline in efferent arteriole
resistance.
UV/CIn or by CNa 1 CH2O/CIn), which suggests a decreaseThe increase of the urine excretion of sodium, chloride
in proximal tubule NaCl and water reabsorption [14].and potassium suggests that this drug has a predominant
The CH2O corrected for glomerular filtration rate was noteffect on the proximal segments of the nephron, such as
altered by artesunate, however, when the CH2O was cor-proximal tubule and the TALHs, with a reduction in the
rected for solute delivery to the distal nephron, a lowerreabsorption of sodium, and an increase in the distal
value was obtained immediately after artesunate infu-sodium delivery with a consequent greater sodium re-
sion, suggesting that a decrease in Na reabsorption oc-absorption and potassium secretion in the collecting tu-
curred in the ascending limb of Henle.bule.
During the hypertonic saline infusion, TcH2O plottedThe results from clearance experiments during water
as a function of COsm was lower following artesunatediuresis showed that artesunate increased the sodium
and water output of the proximal tubule (measured by infusion, indicating that this drug inhibited NaCl reab-
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sorption in the medullary segment of the ascending limb suggesting that the drug can stimulate its renal produc-
tion. A recent study with microperfusion in vitro ofof Henle’s loop [14].
The direct evidence that the TALH is a site of action TALH from rabbits showed that the addition of l-argi-
nine to the basolateral membrane decreased the reab-of artesunate was demonstrated in microperfusion exper-
iments. Wang, Yuan and Wang have shown that artesu- sorption of chloride in this segment and that effect was
blocked by the presence of L-NAME in the bath [21].nate inhibits the Na,K-ATPase enzymatic activity in the
mouse jejunum and in the red blood cell of the rats We verified that the addition of L-NAME also blocked
the effect of sodium artesunate on the TALHs. These[6, 7]. The TALH is the tubular segment that presents
the highest concentration of this enzyme per tubular results suggest that the artesunate stimulates nitric oxide
synthesis in this segment, and this may be one of thelength. Because of the difficulty in isolating the TALH
from the rat, we microperfused this segment from the mechanisms that contributes to its diuretic and natri-
uretic effects as well as to the increase of urine excretionrabbit kidney. The results clearly show that the artesu-
nate reduces the chloride lumen-bath flow only when it of nitrites/nitrates.
Recent studies suggest that nitric oxide and its deriva-is added to the peritubular bath in concentrations in a
dose-dependent manner and it has no effect when added tives can have a protective effect in malaria [22]. Febri-
fugine, another antimalarial drug, reduces the mortalityin high concentration as 1024 mol/L to the perfusion
fluid. These findings suggest that this drug can inhibit and the level of parasitemia in mice infected with plasmo-
dium berghei NH65. These effects were associated withthe Na,K-ATPase at the peritubular membrane or the
basolateral membrane chloride channel and does not an increase in plasma NO3 and were reduced by both
NG-monomethyl-l-arginine and aminoguanidine, indi-act on the Na-2Cl-K cotransporter found in the luminal
membrane. cating that the increased production of nitric oxide by
febrifugine plays an important role in host defenseThe molar concentrations employed in this study are
comparable to the drug’s therapeutic range, since the against malaria infection in mice [23].
It is possible that the antimalarial and systemic effectsmaximum concentration of artesunate after a 2 to
4 mg/kg intravenous dose in humans was 2.64 to of the artesunate occur by way of an increase in nitric
oxide production. The improvement in the acute respira-5.30 mg/L or approximately 1025 mol/L [5, 15].
It is important to emphasize that the effect of artesu- tory failure observed in the case we have reported may
be due to an increase in local production of nitric oxidenate on the TALHs can modify the course of the acute
renal failure from the malaria. The increase of the uri- induced by artesunate. Recent studies showed that nitric
oxide is detectable in the exhaled air of patients withnary loss of water and electrolytes can worsen the hypo-
volemia in these patients who lose a lot of water from adult respiratory distress syndrome (ARDS) at lower
concentrations than in normal subjects [24], and endoge-the high fever and tachypnea, which consequently aggra-
vates renal failure. However, if the volume status is moni- nously produced NO has been reported to be protective
against lung injury [25, 26]. Future studies in animaltored closely, administration of a drug that inhibits so-
dium chloride transport in the TALHs can be useful in models of malaria and artesunate-treated patients with
measurements of NO production and its derivatives willthe conversion of an oliguric renal failure to nonoliguric,
facilitating the management of patients with volume help clarify the mechanism of action of this antimalarial
agent.overload [16]. Studies with patients treated with artesu-
nate in endemic areas of the illness are necessary, in
order to verify whether this drug decreases the incidence ACKNOWLEDGMENTS
of acute renal failure in malaria or whether it modifies These studies were supported by the Instituto dos Laborato´rios
de Investigac¸a˜o Me´dica HC/FMUSP/LIM-12, Fundac¸a˜o Faculdade dethe outcome of this disease.
Medicina, Conselho Nacional de Pesquisa (CNPq), Fundac¸a˜o de Amp-Nitric oxide is an important regulator of urine excre-
aro a` Pesquisa do Estado de Sa˜o Paulo, and by the Universidade
tion of sodium, increasing the natriuresis by inhibiting Federal de Sa˜o Paulo (UNIFESP). Portions of this work were presented
at the 30th and 31st Annual Meetings of the American Society ofthe activity of the Na,K-ATPase and tubular sodium
Nephrology, San Antonio, TX, 1997, and Philadelphia, PA, USA, 1998.transport. In humans, the stimulation of the synthesis of
nitric oxide with l-arginine increases the urine excretion Reprint requests to Antonio Carlos Seguro, M.D., Ph.D., Laborato´rio
de Investigac¸a˜o Me´dica, LIM-12, Faculdade de Medicina de Universi-of sodium, which can be prevented by the inhibition of
dade de Sa˜o Paulo, Av. Doutor Arnaldo 455, 38 andar, sala 3310, CEPthe enzyme responsible for the nitric oxide synthesis
01246-903, Sa˜o Paulo, Brazil.
(NO synthase) with L-NAME [17–19]. NO synthase is
expressed in some segments of the nephron, including
REFERENCES
the TALHs [20].
1. Sitprija V: Nephropathy in falciparum malaria. Kidney Int 33:867–Our study demonstrates that intravenous administra-
877, 1988
tion of sodium artesunate increases the urine excretion 2. Eiam-Ong S, Sitprija V: Falciparum malaria and the kidney: A
model of inflammation. Am J Kidney Dis 32:361–375, 1998of nitrites/nitrates, which are metabolites of nitric oxide,
Campos et al: Artesunate effects on renal function 1051
3. Udomsangpetch R, Pipitaporn B, Krishna S, et al: Antimalarial 15. Khanh NX, de Vries PJ, van Boxtel CJ, et al: Declining concentra-
tions of dihydroartemisin in plasma during day oral treatment withdrugs reduce cytoadherence and rosetting Plasmodium falciparum.
J Infect Dis 173:691–698, 1996 artesunate for Falciparum malaria. Antimicrob Agents Chemother
43:690–692, 19994. Hien TT, White NJ: Qinghaosu. Lancet 341:603–608, 1993
5. Batty KT, Ilett KF, Davis T: Chemical stability of artesunate 16. Kellum JA: Use of diuretics in the acute care setting. Kidney Int
55(Suppl 66):S67–S70, 1998injection and proposal for its administration by intravenous infu-
sion. J Pharm Pharmacol 48:22–26, 1996 17. Conrad KP, Joffe GM, Smith RP, et al: Identification of increased
nitric oxide biosynthesis during pregnancy in rats. FASEB J 7:566–6. Wang JY, Yuan LZ, Wang MD: Inhibition of sodium artesunate
on rat erythrocyte membrane Na(1)-K(1)-exchanging ATPase in 571, 1993
18. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Intvitro. Chung Kuo Yao Li Hsueh Pao 16:524–526, 1995
7. Wang JY, Yuan LZ, Wang MD: Effects of sodium artesunate on 48:20–32, 1995
19. Stoos BA, Garcia NH, Garvin JL: Nitric oxide inhibits sodiumelectrical properties and Na1-K(1)-ATPase activities of mouse
small intestine. Chung Kuo Yao Li Hsueh Pao 11:335–337, 1990 reabsorption in the isolated perfused cortical collecting duct. J Am
Soc Nephrol 6:89–94, 19958. Shimizu T, Nakamura M, Imai M: Renal action of a novel urico-
suric diuretic, S-8666. I. Clearance and tubular microinjection stud- 20. Mohaupt MG, Elzie JL, Ahn KY, et al: Differential expression
and induction of mRNAs encoding two inducible nitric oxide syn-ies in rats. J Pharmacol Exp Ther 245:644–650, 1988
9. Burg MB, Granthan J, Abramov M, et al: Preparation and study thases in rat kidney. Kidney Int 46:653–665, 1994
21. Plato CF, Stoos BA, Wang D, et al: Endogenous nitric oxideof fragments of single rabbit nephrons. Am J Physiol 210:1923–
1928, 1966 inhibits chloride transport in the thick ascending limb. Am J Physiol
276(1 Pt 2):F159–F163, 199910. Green LC, Wagner DA, Glogowsky J, et al: Analysis of nitrate,
nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131– 22. Taylor-Robinson AW, Looker M: Sensitivity of malaria parasites
to nitric oxide at low oxygen tensions. Lancet 351:30, 1998138, 1982
11. Wright FS, Schnermann J: Interference with feedback control of 23. Murata K, Takano F, Fushiya S, et al: Potentiation by febrifugine
of host defense in mice against Plasmodium berghei NK65. Bio-glomerular filtration rate by furosemide, triflocin and cyanide. J Clin
Invest 53:1695–1708, 1974 chem Pharmacol 58:1593–1601, 1999
24. Hart CM: Nitric oxide in adult lung injury. Chest 115:1407–1417,12. Tucker BJ, Blantz RC: Effect of furosemide administration on
glomerular and tubular dynamics in the rat. Kidney Int 26:112–121, 1999
25. Brett SJ, Evans TW: Measurement of endogenous nitric oxide in1984
13. Wilcox CS, Welch WJ: Macula densa nitric oxide synthase: Ex- the lungs of patients with the acute respiratory distress syndrome.
Am J Respir Crit Care Med 157:993–997, 1998pression, regulation, and function. Kidney Int 54(Suppl 67):S53–
S57, 1998 26. Lu YT, Liu SF, Mitchell JA, et al: The role of endogenous nitric
oxide in modulating ischemia-reperfusion injury in the isolated,14. Seldin DW, Eknoyan G, Suki WN, et al: Localization of diuretic
action from the pattern of water and electrolyte excretion. Ann blood-perfused rat lung. Am J Respir Crit Care Med 157:273–279,
1998NY Acad Sci 139:328–343, 1966
